AI in Pharmaceutical R&D with Kim Branson

In this episode, Vijay Pande talks with Kim Branson, the SVP and Global Head of AI and Machine Learning for GSK, about his journey from a childhood fascination with computers to leading AI efforts in a major pharmaceutical company. They discuss Branson's career path, the intersection of computation and biology, and the challenges and opportunities in integrating AI into drug discovery and development. Topics covered: 00:00 - Introduction to Kim Branson and his background 00:15 - Early interest in computers and transition to molecular biology 01:20 - Experience with computational methods in drug design 02:10 - Differences between working in startups and large pharmaceutical companies 04:05 - Decision to join GSK and the company’s commitment to AI 06:10 - Implementing AI in drug discovery processes 08:35 - Use of genetic databases and machine learning in target identification 10:55 - Application of AI in clinical trials and pathology 12:40 - Importance of data in AI-driven drug discovery 16:55 - Challenges of integrating AI into existing pharmaceutical frameworks 18:15 - Advice for startups in the AI and drug discovery space 24:20 - Future of AI in personalized medicine and computational biology Resources: Find Vijay on Twitter: https://x.com/vijaypande Learn more about a16z Bio+Health: https://a16z.com/bio-health/ Learn more about Raising Health: https://a16z.com/podcasts/raising-health/ Stay Updated: Find a16z Bio+Health on LinkedIn: https://www.linkedin.com/showcase/a16z-bio-health/ Find a16z Bio+Health on X: https://x.com/a16zBioHealth Subscribe on your favorite podcast app: https://raisinghealth.simplecast.com/ Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For mor